{"nct_id":"NCT00002255","title":"An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)","status":"COMPLETED","status_verified_date":"1991-01","start_date":null,"start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE1"],"tickers":["AMGN"]}